D.E. Shaw & Co’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-374,300
Closed -$37.2M 4328
2019
Q3
$37.2M Hold
374,300
0.05% 492
2019
Q2
$34.6M Sell
374,300
-533,700
-59% -$50.7M 0.04% 502
2019
Q1
$85.7M Sell
908,000
-34,700
-4% -$3.03M 0.11% 218
2018
Q4
$60.4M Buy
942,700
+393,500
+72% +$29M 0.08% 288
2018
Q3
$49.1M Buy
549,200
+429,000
+357% +$37.9M 0.06% 408
2018
Q2
$9.55M Buy
120,200
+69,400
+137% +$5.76M 0.01% 1103
2018
Q1
$4.53M Sell
50,800
-80,700
-61% -$7.75M 0.01% 1474
2017
Q4
$13.7M Sell
131,500
-280,600
-68% -$31.7M 0.02% 850
2017
Q3
$60.1M Buy
412,100
+330,800
+407% +$45.1M 0.09% 263
2017
Q2
$10.6M Sell
81,300
-168,700
-67% -$20.7M 0.02% 876
2017
Q1
$31.1M Sell
250,000
-94,700
-27% -$11.3M 0.05% 408
2016
Q4
$39.9M Buy
344,700
+99,300
+40% +$11.1M 0.07% 373
2016
Q3
$25.7M Sell
245,400
-17,600
-7% -$1.9M 0.05% 492
2016
Q2
$25.9M Sell
263,000
-138,800
-35% -$14.4M 0.05% 459
2016
Q1
$40.2M Buy
401,800
+4,400
+1% +$453K 0.07% 326
2015
Q4
$47.6M Sell
397,400
-20,900
-5% -$2.42M 0.07% 331
2015
Q3
$45.2M Buy
418,300
+120,900
+41% +$15M 0.07% 343
2015
Q2
$34.4M Sell
297,400
-75,600
-20% -$8.64M 0.05% 432
2015
Q1
$43M Sell
373,000
-187,700
-33% -$22.4M 0.07% 349
2014
Q4
$62.7M Buy
560,700
+8,700
+2% +$918K 0.08% 290
2014
Q3
$52.3M Sell
552,000
-22,200
-4% -$2M 0.07% 335
2014
Q2
$49.3M Buy
574,200
+318,800
+125% +$24.2M 0.07% 333
2014
Q1
$17.8M Buy
255,400
+2,400
+0.9% +$190K 0.03% 709
2013
Q4
$21.4M Sell
253,000
-59,800
-19% -$4.73M 0.03% 646
2013
Q3
$24.1M Buy
312,800
+161,600
+107% +$11.3M 0.04% 506
2013
Q2
$8.84M Buy
+151,200
New +$9.1M 0.02% 949

Other funds holding CELG

D.E. Shaw & Co's CELG Position: Q4 2019 in Review

D.E. Shaw & Co sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 4,627,564 shares — an estimated $460M sold.

D.E. Shaw & Co first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $693M in Q1 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • D.E. Shaw & Co reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • D.E. Shaw & Co sold 4,627,564 Celgene Corp shares in Q4 2019, an estimated $460M.
  • D.E. Shaw & Co first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • D.E. Shaw & Co's Celgene Corp position peaked at $693M in Q1 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on D.E. Shaw & Co's 13F filing for Q4 2019, filed 14 Feb 2020.